Literature DB >> 10678597

Nonparalytic polio and postpolio syndrome.

L S Halstead1, J K Silver.   

Abstract

We describe four cases of postpolio syndrome with typical histories, physical examination results, and electrodiagnostic evidence of extensive anterior horn cell disease, as well as the putative pathophysiology of postpolio syndrome in persons with histories of nonparalytic polio and the diagnostic implications for individuals older than 40 yr of age who are experiencing unexplained new weakness, fatigue, and muscle or joint pain. Although the diagnosis of postpolio syndrome traditionally has required a remote history of paralytic polio, many persons such as the ones described here with typical symptoms of postpolio syndrome have no clear history of paralytic disease and are being misdiagnosed. With this in mind, we believe that the diagnostic criteria for postpolio syndrome should be modified to include the following: a history of remote paralytic polio or findings on history, physical examination results, and laboratory studies compatible with poliovirus damage of the central nervous system earlier in life.

Entities:  

Mesh:

Year:  2000        PMID: 10678597     DOI: 10.1097/00002060-200001000-00005

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  3 in total

1.  Perceived health in a population based sample of victims of the 1956 polio epidemic in the Netherlands.

Authors:  F Nollet; B Ivanyi; A Beelen; R J De Haan; G J Lankhorst; M De Visser
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

2.  Long term outcome after poliomyelitis in different health and social conditions.

Authors:  T Rekand; J Kõrv; E Farbu; M Roose; N E Gilhus; N Langeland; J A Aarli
Journal:  J Epidemiol Community Health       Date:  2003-05       Impact factor: 3.710

3.  Patients with post-polio syndrome are more likely to have subclinical involvement as compared to polio survivors without new symptoms.

Authors:  Arzu Yağız On; Ulaş Sungur
Journal:  Ann Indian Acad Neurol       Date:  2016 Jan-Mar       Impact factor: 1.383

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.